Search for

Search Results

58 Search Results

Recent advances in pancreatic cancer: From screening protocols to precision medicine paradigms

Pancreatic ductal adenocarcinoma, or PDAC, is the third most common cause of cancer-related death in the United States, with a median 5-year survival rate of only 9%. Incidence of this cancer is rising, an effect of an aging population, improved diagnostics and the so-called “diabesity” epidemic.However, there have been several recent advances in PDAC, from […]

The fluid that feeds tumor cells

Before being tested in animals or humans, most cancer drugs are evaluated in tumor cells grown in a lab dish. However, in recent years, there has been a growing realization that the environment in which these cells are grown does not accurately mimic the natural environment of a tumor, and that this discrepancy could produce […]

Genome-Wide Analysis Reveals New Strategies to Target Pancreatic Cancer

For some cancers, initial treatment with chemotherapy brings positive, but only temporary, results: tumors shrink, but then rebound as the cancer becomes drug-resistant. This pattern of remission-resistance-relapse is particularly true for pancreatic cancer, an aggressive disease in which early success is often countered by eventual disease progression. To wit: The one-year relative survival rate for […]

Mayo Clinic finds 3 factors may extend life for pancreatic cancer patients

 A new study from the Mayo Clinic found that a pre-surgery treatment plan may help extend life for advanced pancreatic cancer patients. According to Mayo researchers, most pancreatic cancer patients whose tumors grow outside the pancreas and encompass veins and arteries have been told the cancer is inoperable and they should prepare for an average survival time of 12 to 18 months. […]

Back to Top